Safety and Efficacy of Combigan® Ophthalmic Solution in Korea

Allergan

Status: Completed

Conditions: Ocular Hypertension; Glaucoma, Open-Angle

Treatments: Drug: brimonidine tartrate/timolol maleate Ophthalmic Solution

Study type: Observational

Funder types: Industry

Identifiers

NCT01987752

190342-040

Details and patient eligibility

About

This study is a Post-Marketing Surveillance study in Korea to evaluate the safety and efficacy of Combigan® (brimonidine tartrate/timolol maleate) Ophthalmic Solution in patients with Open Angle Glaucoma or Ocular hypertension with insufficient response to local beta blockers treated as per standard of care in clinical practice.

Enrollment: 732 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with Open Angle Glaucoma or Ocular Hypertension treated with Combigan® Ophthalmic Solution as standard of care in clinical practice.

Exclusion criteria

• None.

Trial design

732 participants in 1 patient group

Combigan® Ophthalmic Solution

Description:

Patients treated with Combigan® Ophthalmic Solution as per local standard of care in clinical practice.

Treatment:

Drug: brimonidine tartrate/timolol maleate Ophthalmic Solution